{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:42:10Z","timestamp":1790206930157,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1007\/s11894-007-0055-7","type":"journal-article","created":{"date-parts":[[2007,10,2]],"date-time":"2007-10-02T18:15:36Z","timestamp":1191348936000},"page":"434-440","source":"Crossref","is-referenced-by-count":16,"title":["Probiotics in the management of colonic disorders"],"prefix":"10.1007","volume":"9","author":[{"given":"Eamonn M. M.","family":"Quigley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,10,3]]},"reference":[{"key":"55_CR1","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1128\/MMBR.62.4.1157-1170.1998","volume":"62","author":"P.G. Falk","year":"1998","unstructured":"Falk PG, Hooper LV, Mittvedt T, Gordon JI: Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol Mol Biol Rev 1998, 62:1157\u20131170.","journal-title":"Microbiol Mol Biol Rev"},{"key":"55_CR2","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1053\/bega.2002.0342","volume":"16","author":"F. Shanahan","year":"2002","unstructured":"Shanahan F: The host-microbe interface within the gut. Best Pract Research Clin Gastroenterol 2002, 16:915\u2013931.","journal-title":"Best Pract Research Clin Gastroenterol"},{"key":"55_CR3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cgh.2006.12.009","volume":"5","author":"A.M. O\u2019Hara","year":"2007","unstructured":"O\u2019Hara AM, Shanahan F: Gut microbiota: mining for therapeutic potential. Clin Gastroenterol Hepatol 2007, 5:274\u2013284.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"55_CR4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0140-6736(03)12489-0","volume":"361","author":"F. Guarner","year":"2003","unstructured":"Guarner F, Malagelada JR: Gut flora in health and disease. Lancet 2003, 361:512\u2013519.","journal-title":"Lancet"},{"issue":"Suppl2","key":"55_CR5","doi-asserted-by":"crossref","first-page":"830S","DOI":"10.1093\/jn\/137.3.830S","volume":"137","author":"M. Roberfroid","year":"2007","unstructured":"Roberfroid M: Prebiotics: the concept revisited. J Nutr 2007, 137(Suppl 2):830S\u2013837S.","journal-title":"J Nutr"},{"key":"55_CR6","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1053\/j.gastro.2003.11.019","volume":"126","author":"D. Rachmilewitz","year":"2004","unstructured":"Rachmilewitz D, Kayatura, Karmeli F, et al.: Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004, 126:520\u2013528.","journal-title":"Gastroenterology"},{"issue":"Suppl","key":"55_CR7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/00855910310001476","volume":"38","author":"F. Shanahan","year":"2003","unstructured":"Shanahan F: Probiotics: a perspective on problems and pitfalls. Scand J Gastroenterol 2003, 38(Suppl):34\u201336.","journal-title":"Scand J Gastroenterol"},{"key":"55_CR8","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00005176-200610000-00036","volume":"43","author":"S. Michail","year":"2006","unstructured":"NASPGHAN Nutrition Report Committee, Michail S, Sylvester F, Fuchs G, Issenman R: Clinical efficacy of probiotics: review of the evidence with focus on children. J Pediatr Gastroenterol Nutr 2006, 43:550\u2013557.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"55_CR9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bpg.2003.10.006","volume":"18","author":"E. Isolauri","year":"2004","unstructured":"Isolauri E, Salminen S, Ouwehand AC: Microbial-gut interactions in health and disease. Probiotics. Best Pract Res Clin Gastroenterol 2004, 18:299\u2013313.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"55_CR10","doi-asserted-by":"crossref","unstructured":"Allen SJ, Okoko B, Martinez E, et al.: Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev 2004, (2):CD003048.","DOI":"10.1002\/14651858.CD003048.pub2"},{"key":"55_CR11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00042737-200104000-00015","volume":"13","author":"H. Urbancsek","year":"2003","unstructured":"Urbancsek H, Kazar T, Mezes I, et al.: results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhea. Eur J Gastroenterol Hepatol 2003, 13:391\u2013396.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"55_CR12","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3748\/wjg.v13.i6.912","volume":"13","author":"P. Delia","year":"2007","unstructured":"Delia P, Sansotta G, Donato V, et al.: Use of probiotics for prevention of radiation-induced diarrhea. World J Gastroenterol 2007, 13:912\u2013915.","journal-title":"World J Gastroenterol"},{"key":"55_CR13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.tmaid.2005.10.003","volume":"5","author":"L.V. McFarland","year":"2007","unstructured":"McFarland LV: Meta-analysis of probiotics for the prevention of traveler\u2019s diarrhea. Travel Med Infect Dis 2007, 5:97\u2013105.","journal-title":"Travel Med Infect Dis"},{"key":"55_CR14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2036.2006.03202.x","volume":"25","author":"H. Szajewska","year":"2007","unstructured":"Szajewska H, Skorka A, Dylag M: Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Aliment Pharmacol Ther 2007, 25:257\u2013264.","journal-title":"Aliment Pharmacol Ther"},{"key":"55_CR15","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1136\/bmj.324.7350.1361","volume":"324","author":"A.L. D\u2019souza","year":"2002","unstructured":"D\u2019souza AL, Rajkumar CH, Cooke J, et al.: Probiotics in prevention of antibiotic associated diarrhea: meta-analysis. BMJ 2002, 324:1361\u20131366.","journal-title":"BMJ"},{"key":"55_CR16","first-page":"334","volume":"100","author":"M.C. Ahuja","year":"2002","unstructured":"Ahuja MC Khamar B: Antibiotic associated diarrhea: a controlled study comparing plain antibiotic with those containing protected lactobacilli. J Indian Med Assoc 2002, 100:334\u2013335.","journal-title":"J Indian Med Assoc"},{"key":"55_CR17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S1473-3099(06)70495-9","volume":"6","author":"S. Sazawal","year":"2006","unstructured":"Sazawal S, Hiremath G, Dhingra U, et al.: Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 2006, 6:374\u2013382.","journal-title":"Lancet Infect Dis"},{"issue":"Suppl2","key":"55_CR18","doi-asserted-by":"crossref","first-page":"803S","DOI":"10.1093\/jn\/137.3.803S","volume":"137","author":"M. Vrese de","year":"2007","unstructured":"de Vrese M, Marteau PR: Probiotics and prebiotics: effects on diarrhea. J Nutr 2007, 137(Suppl 2):803S\u2013811S.","journal-title":"J Nutr"},{"key":"55_CR19","doi-asserted-by":"crossref","unstructured":"Chande N, McDonald JW, MacDonald JK: Interventions for treating collagenous colitis. Cochrane Database Syst Rev 2006:CD003575.","DOI":"10.1002\/14651858.CD003575.pub4"},{"key":"55_CR20","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1155\/2003\/654907","volume":"17","author":"C. Koebnick","year":"2003","unstructured":"Koebnick C, Wagner I, Leitzmann P, et al.: Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol 2003, 17:655\u2013659.","journal-title":"Can J Gastroenterol"},{"key":"55_CR21","first-page":"157","volume":"77","author":"M. Amenta","year":"2006","unstructured":"Amenta M, Cascio MT, Di Fiore P, Venturini I: Diet and chronic constipation. Benefits of oral supplementation with symbiotic zir fos (Bifidobacterium longum W11 + FOS Actilight). Acta Biomed 2006, 77:157\u2013162.","journal-title":"Acta Biomed"},{"key":"55_CR22","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jpeds.2004.10.022","volume":"146","author":"A. Banaszkiewicz","year":"2005","unstructured":"Banaszkiewicz A, Szajewska H: Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: a double-blind, placebo-controlled randomized trial. J Pediatr 2005, 146:364\u2013369.","journal-title":"J Pediatr"},{"key":"55_CR23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000063075","volume":"46","author":"A.C. Ouwehand","year":"2002","unstructured":"Ouwehand AC, Lagstrom H, Suomalainen T, Salminen S: Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Ann Nutr Metab 2002, 46:159\u2013162.","journal-title":"Ann Nutr Metab"},{"key":"55_CR24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/01.mcg.0000128988.13808.dc","volume":"38","author":"T.J. Borody","year":"2004","unstructured":"Borody TJ, Warren EF, Leis SM, et al.: Bacteriotherapy using fecal flora: toying with human motions. J Clin Gastroenterol 2004, 38:475\u2013483.","journal-title":"J Clin Gastroenterol"},{"key":"55_CR25","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1572-0241.2006.00445.x","volume":"101","author":"E.M. Quigley","year":"2006","unstructured":"Quigley EM: Germs, gas and the gut, the evolving role of the enteric flora in IBS. Am J Gastroenterol 2006, 101:334\u2013335.","journal-title":"Am J Gastroenterol"},{"key":"55_CR26","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1046\/j.1365-2036.2003.01543.x","volume":"17","author":"H.J. Kim","year":"2003","unstructured":"Kim HJ, Camilleri M, McKenzie S, et al.: A randomized controlled trail of a probiotic, VSL#3 on gut transit and symptoms in diarrhoea-predominant IBS. Aliment Pharmacol Ther 2003, 17:895\u2013904.","journal-title":"Aliment Pharmacol Ther"},{"key":"55_CR27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2982.2005.00695.x","volume":"17","author":"H.J. Kim","year":"2005","unstructured":"Kim HJ, Vazquez Roque MI, Camilleri M, et al.: a randomised controlled trial of probiotic combination VSL#3 and placebo in IBS with bloating: Neurogastroenterol Motil 2005, 17:687\u2013696.","journal-title":"Neurogastroenterol Motil"},{"key":"55_CR28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2004.11.050","volume":"128","author":"L. O\u2019Mahony","year":"2005","unstructured":"O\u2019Mahony L, McCarthy J, Kelly P, et al.: Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005, 128:541\u2013551.","journal-title":"Gastroenterology"},{"key":"55_CR29","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1572-0241.2006.00734.x","volume":"101","author":"P.J. Whorwell","year":"2006","unstructured":"Whorwell PJ, Altinger L, Morel J, et al.: Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006, 101, 326\u2013333.","journal-title":"Am J Gastroenterol"},{"key":"55_CR30","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/IAI.67.1.302-307.1999","volume":"67","author":"I. Castagliuolo","year":"1999","unstructured":"Castagliuolo I, Riegler MF, Valenik L, et al.: Saccharomyces boulardii protease inhibits the effects of clostridium difficile toxins A an B in human colonic mucosa. Infect Immun 1999, 67.302\u2013307.","journal-title":"Infect Immun"},{"key":"55_CR31","doi-asserted-by":"crossref","first-page":"24449","DOI":"10.1074\/jbc.M605200200","volume":"281","author":"X. Chen","year":"2006","unstructured":"Chen X, Kokkotou EG, Mustafa N, et al.: Saccharomyces boulardii inhibits ERK1\/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis. J Biol Chem 2006, 281:24449\u201324454.","journal-title":"J Biol Chem"},{"key":"55_CR32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/00365540310010985","volume":"35","author":"M. Wullt","year":"2003","unstructured":"Wullt M, Hagslatt ML, Odenholt I: Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial. Scand J Infect Dis 2003, 35:365\u2013367.","journal-title":"Scand J Infect Dis"},{"key":"55_CR33","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1572-0241.2006.00465.x","volume":"101","author":"L.V. McFarland","year":"2006","unstructured":"McFarland LV: Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006, 101:812\u2013822.","journal-title":"Am J Gastroenterol"},{"key":"55_CR34","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2982.2006.00879.x","volume":"19","author":"E.M. Quigley","year":"2007","unstructured":"Quigley EM, Flourie B: Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date. Neurogastroenterol Motil 2007, 19:166\u2013172.","journal-title":"Neurogastroenterol Motil"},{"key":"55_CR35","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/089106001753341282","volume":"13","author":"J.M.T. Hamilton-Miller","year":"2001","unstructured":"Hamilton-Miller JMT: Probiotics in the management of irritable bowel syndrome: A review of clinical trials. Microb Ecol Health Dis 2001, 13:212\u2013216.","journal-title":"Microb Ecol Health Dis"},{"issue":"Suppl3","key":"55_CR36","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1097\/01.mcg.0000225502.29498.ba","volume":"40","author":"M.H. Floch","year":"2006","unstructured":"Floch MH: A hypothesis: is diverticulitis a type of inflammatory bowel disease? J Clin Gastroenterol 2006, 40(Suppl 3):S121\u2013S125.","journal-title":"J Clin Gastroenterol"},{"key":"55_CR37","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/01.mcg.0000210092.77296.6d","volume":"40","author":"A. Tursi","year":"2006","unstructured":"Tursi A, Brandimarte G, Giorgetti GM, Elisei W: Mesalazine and\/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open-label study. J Clin Gastroenterol 2006, 40:312\u2013316.","journal-title":"J Clin Gastroenterol"},{"issue":"Suppl2","key":"55_CR38","doi-asserted-by":"crossref","first-page":"819S","DOI":"10.1093\/jn\/137.3.819S","volume":"137","author":"B. Sheil","year":"2007","unstructured":"Sheil B, Shanahan F, O\u2019Mahony L: Probiotic effects on inflammatory bowel disease. J Nutr 2007, 137(Suppl 2):819S\u2013824S.","journal-title":"J Nutr"},{"key":"55_CR39","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s11894-006-0039-z","volume":"8","author":"J.B. Ewaschuk","year":"2006","unstructured":"Ewaschuk JB, Tejpar QZ, Soo I, et al.: The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease. Curr Gastroenterol Rep 2006, 8:486\u2013498.","journal-title":"Curr Gastroenterol Rep"},{"key":"55_CR40","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1053\/j.gastro.2004.03.024","volume":"126","author":"R.B. Sartor","year":"2004","unstructured":"Sartor RB: Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004, 126:1620\u20131633.","journal-title":"Gastroenterology"},{"key":"55_CR41","doi-asserted-by":"crossref","first-page":"G417","DOI":"10.1152\/ajpgi.00421.2004","volume":"288","author":"F. Shanahan","year":"2005","unstructured":"Shanahan F: Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases I. Pathophysiological basis and prospects for probiotic therapy in inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 2005, 288:G417\u2013G421.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"55_CR42","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/gut.52.7.975","volume":"52","author":"J. McCarthy","year":"2003","unstructured":"McCarthy J, O\u2019Mahony L, O\u2019Callaghan L, et al.: Double-blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokines. Gut 2003, 52:975\u2013980.","journal-title":"Gut"},{"key":"55_CR43","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1368-5031.2006.00833.x","volume":"60","author":"A.P. Bai","year":"2006","unstructured":"Bai AP, Ouyang Q, Xiao XR, Li SF: Probiotics modulate inflammatory cytokine secretion from inflamed mucosa in active ulcerative colitis. Int J Clin Pract 2006, 60:284\u2013288.","journal-title":"Int J Clin Pract"},{"key":"55_CR44","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3748\/wjg.v10.i10.1521","volume":"10","author":"H.H. Cui","year":"2004","unstructured":"Cui HH, Chen CL, Wang JD, et al.: Effects of probiotic on intestinal mucosa of patients with ulcerative colitis. World J Gastroenterol 2004, 10:1521\u20131525.","journal-title":"World J Gastroenterol"},{"key":"55_CR45","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/gut.51.5.659","volume":"51","author":"N. Borruel","year":"2002","unstructured":"Borruel N, Carol M, Casellas F, et al.: Increased mucosal tumour necrosis factor alpha production in Crohn\u2019s disease can be downregulated ex vivo by probiotic bacteria. Gut 2002, 51:659\u2013664.","journal-title":"Gut"},{"key":"55_CR46","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1128\/IAI.01449-05","volume":"74","author":"A. Grabig","year":"2006","unstructured":"Grabig A, Paclik D, Guzy C, et al.: Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2-and toll-like receptor 4-dependent pathways. Infect Immun 2006, 74:4075\u20134082.","journal-title":"Infect Immun"},{"key":"55_CR47","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1365-2036.1997.00225.x","volume":"11","author":"W. Kruis","year":"1997","unstructured":"Kruis W, Schutz E, Fric P, et al.: Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 1997, 11:853\u2013858.","journal-title":"Aliment Pharmacol Ther"},{"key":"55_CR48","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(98)06343-0","volume":"354","author":"B.J. Rembacken","year":"1999","unstructured":"Rembacken BJ, Snelling AM, Hawkey PM, et al.: Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 1999, 354:635\u2013639.","journal-title":"Lancet"},{"key":"55_CR49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/07315724.2003.10719276","volume":"22","author":"H. Ishikawa","year":"2003","unstructured":"Ishikawa H, Akedo I, Umesaki Y, et al.: Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. J Am Coll Nutr 2003, 22:55\u201363.","journal-title":"J Am Coll Nutr"},{"key":"55_CR50","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1136\/gut.2003.037747","volume":"53","author":"W. Kruis","year":"2004","unstructured":"Kruis W, Fric P, Pokrotnieks J, et al.: Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004, 53:1617\u20131623.","journal-title":"Gut"},{"key":"55_CR51","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/j.1365-2036.2006.02927.x","volume":"23","author":"M.A. Zocco","year":"2006","unstructured":"Zocco MA, dal Verme LZ, Cremonini F, et al.: Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 2006, 23:1567\u20131574.","journal-title":"Aliment Pharmacol Ther"},{"key":"55_CR52","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1365-2036.2004.02268.x","volume":"20","author":"K. Kato","year":"2004","unstructured":"Kato K, Mizuno S, Umesaki Y, et al.: Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Aliment Pharmacol Ther 2004, 20:1133\u20131141.","journal-title":"Aliment Pharmacol Ther"},{"key":"55_CR53","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00042737-200306000-00017","volume":"15","author":"M. Guslandi","year":"2003","unstructured":"Guslandi M, Giollo P, Testoni PA: A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur J Gastroenterol Hepatol 2003, 15:697\u2013698.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"55_CR54","first-page":"PI126","volume":"10","author":"A. Tursi","year":"2004","unstructured":"Tursi A, Brandimarte G, Giorgetti GM, et al.: Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. Med Sci Monit 2004, 10:PI126\u2013PI131.","journal-title":"Med Sci Monit"},{"key":"55_CR55","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1572-0241.2005.41794.x","volume":"100","author":"R. Bibiloni","year":"2005","unstructured":"Bibiloni R, Fedorak RN, Tannock GW, et al.: VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 2005, 100:1539\u20131546.","journal-title":"Am J Gastroenterol"},{"key":"55_CR56","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00004836-200307000-00012","volume":"37","author":"T.J. Borody","year":"2003","unstructured":"Borody TJ, Warren EF, Leis S, et al.: Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 2003, 37:42\u201347.","journal-title":"J Clin Gastroenterol"},{"key":"55_CR57","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0016-5085(03)00171-9","volume":"124","author":"P. Gionchetti","year":"2003","unstructured":"Gionchetti P, Rizzello F, Helwig U, et al.: Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003, 124:1202\u20131209.","journal-title":"Gastroenterology"},{"key":"55_CR58","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/gut.53.1.108","volume":"53","author":"T. Mimura","year":"2004","unstructured":"Mimura T, Rizzello F, Helwig U, et al.: Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004, 53:108\u2013114.","journal-title":"Gut"},{"key":"55_CR59","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s10350-004-0525-z","volume":"47","author":"M.P. Gosselink","year":"2004","unstructured":"Gosselink MP, Schouten WR, van Lieshout LM, et al.: Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG. Dis Colon Rectum 2004, 47:876\u2013884.","journal-title":"Dis Colon Rectum"},{"key":"55_CR60","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1365-2036.2003.01465.x","volume":"17","author":"J. Kuisma","year":"2003","unstructured":"Kuisma J, Mentula S, Jarvinen H, et al.: Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora. Aliment Pharmacol Ther 2003, 17:509\u2013515.","journal-title":"Aliment Pharmacol Ther"},{"key":"55_CR61","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/00365520410009339","volume":"40","author":"K.O. Laake","year":"2005","unstructured":"Laake KO, Bjorneklett A, Aamodt G, Aabakken et al.: Outcome of four weeks\u2019 intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-analanastomosis in ulcerative colitis. Scand J Gastroenterol 2005, 40:43\u201351.","journal-title":"Scand J Gastroenterol"},{"key":"55_CR62","first-page":"4179","volume":"A781","author":"M. Campieri","year":"2000","unstructured":"Campieri M, Rizzello F, Venturi A, et al.: Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn\u2019s disease: a randomized controlled study vs mesalamine. Gastroenterology 2000, A781:4179.","journal-title":"Gastroenterology"},{"key":"55_CR63","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1023\/A:1005588911207","volume":"45","author":"M. Guslandi","year":"2000","unstructured":"Guslandi M, Mezzi G, Sorghi M, Testoni PA: Saccharomyces boulardii in maintenance treatment of Crohn\u2019s disease. Dig Dis Sci 2000, 45:1462\u20131464.","journal-title":"Dig Dis Sci"},{"key":"55_CR64","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00005176-200010000-00024","volume":"31","author":"P. Gupta","year":"2000","unstructured":"Gupta P, Andrew H, Kirschner BS, Guandalini S: Is lactobacillus GG helpful in children with Crohn\u2019s disease? Results of a preliminary, open-label study. J Pediatr Gastroenterol Nutr 2000, 31:453\u2013457.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"55_CR65","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1358\/dot.2005.41.7.917341","volume":"41","author":"O. Karimi","year":"2005","unstructured":"Karimi O, Pena AS, van Bodegraven AA: Probiotics (VSL#3) in arthralgia in patients with ulcerative colitis and Crohn\u2019s disease: a pilot study. Drugs Today (Barc) 2005, 41:453\u2013459.","journal-title":"Drugs Today (Barc)"},{"key":"55_CR66","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/gut.51.3.405","volume":"51","author":"C. Prantera","year":"2002","unstructured":"Prantera C, Scribano ML, Falasco G, et al.: Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn\u2019s disease: a randomised controlled trial with Lactobacillus GG. Gut 2002, 51:405\u2013409.","journal-title":"Gut"},{"key":"55_CR67","doi-asserted-by":"crossref","unstructured":"Rolfe VE, Fortun PJ, Hawkey CJ, Bath-Hextall F: Probiotics for maintenance of remission in Crohn\u2019s disease. Cochrane Database Syst Rev 2006, 18:CD004826.","DOI":"10.1002\/14651858.CD004826.pub2"},{"key":"55_CR68","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/gut.2005.076604","volume":"55","author":"P. Marteau","year":"2006","unstructured":"Marteau P, Lemann M, Seksik P, et al.: Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn\u2019s disease: a randomised, double blind, placebo controlled GETAID trial. Gut 2006, 55:842\u2013847.","journal-title":"Gut"},{"key":"55_CR69","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/01.MIB.0000175905.00212.2c","volume":"11","author":"A. Bousvaros","year":"2005","unstructured":"Bousvaros A, Guandalini S, Baldassano RN, et al.: A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn\u2019s disease. Inflamm Bowel Dis 2005, 11:833\u2013839.","journal-title":"Inflamm Bowel Dis"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-007-0055-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-007-0055-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-007-0055-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:25:27Z","timestamp":1587947127000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-007-0055-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["55"],"URL":"https:\/\/doi.org\/10.1007\/s11894-007-0055-7","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}